Edition:
United Kingdom

Syngene International Ltd (SYNN.NS)

SYNN.NS on National Stock Exchange of India

538.85INR
15 Dec 2017
Change (% chg)

Rs-1.80 (-0.33%)
Prev Close
Rs540.65
Open
Rs545.00
Day's High
Rs549.40
Day's Low
Rs536.00
Volume
99,557
Avg. Vol
115,680
52-wk High
Rs617.55
52-wk Low
Rs430.10

Latest Key Developments (Source: Significant Developments)

Bristol-Myers and Syngene expand ongoing research collaboration
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Syngene International ::Bristol-Myers Squibb and Syngene International expand ongoing research collaboration.Says collaboration with Bristol-Myers Squibb extended until 2026​.  Full Article

Syngene International ‍expands collaboration with Bristol-Myers Squibb​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Syngene International Ltd ::Says ‍expanded collaboration with Bristol-Myers Squibb​.Nnext phase of partnership will see addition of facility to support future Bristol-Myers Squibb research and development operations​.  Full Article

India's Syngene International Sept-qtr profit rises 3 pct
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Syngene International Ltd :Sept quarter net profit 769 million rupees versus profit of 747 million rupees last year.Sept quarter revenue from operations 3.35 billion rupees versus 3.03 billion rupees last year.  Full Article

Syngene International says no loss of life at lab fire
Tuesday, 13 Dec 2016 

Syngene International Ltd :Syngene International Ltd says fire last night at one laboratory building; no loss of life or any injury.  Full Article

Syngene International June-qtr profit rises
Thursday, 21 Jul 2016 

Syngene International Ltd : June-quarter net profit 598 million rupees versus 466 million rupees last year . June-quarter net sales 2.69 billion rupees versus 2.28 billion rupees last year . Two new facilities are now operational-first phase of Syngene research centre and a viral testing facility .  Full Article

BRIEF-Bristol-Myers and Syngene expand ongoing research collaboration

* Bristol-Myers Squibb and Syngene International expand ongoing research collaboration